Dr. Scott W. Biggins is Professor of Medicine & UPMC Endowed Chair for Patient Centered Care, Chief of Hepatology, Director of UPMC Liver Care, Medical Director of Liver Transplant and Co-Director of Clinical Research at the University of Pittsburgh Starzl Transplant Institute. Dr. Biggins is a nationally recognized clinician and researcher in the field of Hepatology. He received his undergraduate degree in chemical engineering (bioengineering option) from UCLA and his medical degree from USC.

Prof. Dr. Heiner Wedemeyer is Director of the Department of Gastroenterology, Hepatology, Infectious Diseases, and Endocrinology at Hannover Medical School (MHH).

I am a transplant hepatologist with a research focus at the intersection of nephrology and hepatology.

I am a Professor of Medicine and section chief of Hepatology in the Division of Gastroenterology and Hepatology at the University of Wisconsin School of Medicine and Public Health. In addition, I am the medical director of Liver Transplantation for the UW Health Transplant Center.

Dr. Dove has been a transplant hepatologist for more than twenty years and is now the Division Chief of Hepatology at University of Arizona in Tucson

Dr. Bend Schnabl is a trained gastroenterologist and physician-scientist. He received his MD degree from the University Freiburg in Germany. After finishing his residency in internal medicine, he completed a gastroenterology fellowship at Columbia University in New York City. He is currently Professor of Medicine in the Division of Gastroenterology at UC San Diego. Dr. Schnabl is staff physician and attending at the VA San Diego Medical Center in La Jolla and the UCSD Medical Center. He is the Director of the NIH-funded San Diego Digestive Diseases Research Center (SDDRC).

The Prinz lab studies organelle biogenesis and intracellular lipid trafficking and homeostasis. There are several related questions we are working to answer:
What is the mechanism and function of lipid exchange at membrane contacts sites?
How do ER-subdomains form and how do they contribute to lipid metabolism and organelle biogenesis?
How are lipid droplets and lipoproteins, such as VLDL produced, in the ER?

Ling Yang, Ph.D., is a Professor at the University of Iowa Carver College of Medicine and a core member of the Fraternal Order of Eagles Diabetes Research Center. She received her Ph.D. from Kent State University and completed postdoctoral training with Gökhan Hotamisligil at Harvard T.H. Chan School of Public Health. Dr. Yang's research focuses on organelle stress signaling and immunometabolic regulation in obesity, MASLD/MASH, diabetes, and cardiovascular disease.

Pavel Strnad is a department chair at the Medical University of Lausitz in Cottbus, Germany. Since 2008, he is heading his own research lab focusing on translational gastroenterology. In 2016, he was named one of the Rising Stars of the United European Gastroenterology. He is heading the European initiative for study of alpha1-antitrypsin deficiency-associated liver disease. His interests include metabolic liver disease, liver cirrhosis and complications as well as analysis of complex datasets. His clinical focus is on emerging drugs, end-stage liver disease and liver transplantation.